AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20646083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 20646083 — intervention group
Group type: EXPERIMENTAL
Intervention: WEO
Number of subjects: 51
Study 18821119 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% pramoxine hydrochloride lotion applied twice daily for 4 weeks
Number of subjects: 28
Study 18821119 — intervention group
Group type: COMPARATOR
Intervention: Control lotion
Number of subjects: 28
Study 17892995 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor with half-dose t-PA
Number of subjects: 92
Study 17892995 — intervention group
Group type: COMPARATOR
Intervention: Full-dose t-PA
Number of subjects: 92
Study 17892995 — intervention group
Group type: COMPARATOR
Intervention: Cangrelor alone
Number of subjects: 92
Study 17113442 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg prednisolone intramuscularly immediately after surgery
Number of subjects: 45
Study 17113442 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg prednisolone and diclofenac intramuscularly immediately after surgery
Number of subjects: 45
Study 17113442 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline solution (control group)
Number of subjects: 45
Study 15604833 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty and stenting
Number of subjects: 0
Study 15604833 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 0
Study 11110934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary radiation therapy (RT)
Number of subjects: 12
Study 8958363 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg orally daily
Number of subjects: 20
Study 8958363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1526735 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous epinephrine infusion (1 microgram/hr)
Number of subjects: 20
Study 1526735 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 20
Study 3915865 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximate staple closure
Number of subjects: 57
Study 3915865 — intervention group
Group type: COMPARATOR
Intervention: Suture closure (3/0 Prolene)
Number of subjects: 57
Study 30108104 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab (FOLFIRI+Cetux)
Number of subjects: 340
Study 30108104 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab (FOLFIRI+Beva)
Number of subjects: 340
Study 28836054 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib therapy
Number of subjects: 69
Study 28836054 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCB1 polymorphisms study
Number of subjects: 69
Study 28836054 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis
Number of subjects: 69
Study 25882384 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination training (AT/RT)
Number of subjects: 196
Study 25882384 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 196
Study 25882384 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RT)
Number of subjects: 196
Study 23792286 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained painful proximal gastric balloon distension (PAIN)
Number of subjects: 20
Study 23792286 — intervention group
Group type: COMPARATOR
Intervention: No distension (NO PAIN)
Number of subjects: 20
Study 21784436 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support and earlier SCPC
Number of subjects: 230
Study 19317379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon, 8 mg
Number of subjects: 33
Study 19317379 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem, 10 mg (positive control)
Number of subjects: 33
Study 19317379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 18210981 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical equipoise
Number of subjects: 0
Study 18210981 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller and Weijer's defense of clinical equipoise
Number of subjects: 0
Study 15554771 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 600 mg/day b.i.d. for 5 days
Number of subjects: 20
Study 15554771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11672449 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy with transdermal oestradiol (50 microg/24 h patch or 1 mg/day gel) combined with oral dihydrogesterone (10 mg/day for 12 days/month, days 19-30).
Number of subjects: 22
Study 9926031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 0
Study 9926031 — intervention group
Group type: COMPARATOR
Intervention: Psychological treatments
Number of subjects: 0
Study 8161382 — intervention group
Group type: COMPARATOR
Intervention: Dihydroergotamine alone (N=177)
Number of subjects: 311
Study 8161382 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine with concomitant antiemetic (N=133)
Number of subjects: 311
Study 3364231 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring group
Number of subjects: 0
Study 3364231 — intervention group
Group type: COMPARATOR
Intervention: No self-monitoring control group
Number of subjects: 0
Study 29804377 — intervention group
Group type: EXPERIMENTAL
Intervention: ETV monotherapy
Number of subjects: 580
Study 29804377 — intervention group
Group type: COMPARATOR
Intervention: LAM and ADV combination therapy
Number of subjects: 580
Study 28044367 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% anthralin ointment
Number of subjects: 30
Study 28044367 — intervention group
Group type: COMPARATOR
Intervention: Untreated side of the scalp (control)
Number of subjects: 30
Study 25280988 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized cushion
Number of subjects: 40
Study 25280988 — intervention group
Group type: COMPARATOR
Intervention: Conventional cushion
Number of subjects: 40
Study 23715641 — intervention group
Group type: EXPERIMENTAL
Intervention: Jitai tablets
Number of subjects: 64
Study 23715641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 21635609 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography (ECHO group)
Number of subjects: 156
Study 21635609 — intervention group
Group type: COMPARATOR
Intervention: Electrocardiography (ECG group)
Number of subjects: 156
Study 17399814 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of simvastatin daily (n=40)
Number of subjects: 60
Study 17399814 — intervention group
Group type: COMPARATOR
Intervention: Hypolipidaemic only diet (n=20)
Number of subjects: 60
Study 17262124 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave disinfection (690 W for 6 min)
Number of subjects: 18
Study 17262124 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical disinfection (immersion in 100 ppm chloride solution)
Number of subjects: 18
Study 17262124 — intervention group
Group type: COMPARATOR
Intervention: Control (no disinfection)
Number of subjects: 18
Study 17262124 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical polishing with microwave disinfection
Number of subjects: 18
Study 17262124 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical polishing with chemical disinfection
Number of subjects: 18
Study 15228176 — intervention group
Group type: EXPERIMENTAL
Intervention: Tutoring intervention with three 30-min sessions per week during 1st grade
Number of subjects: 581
Study 15228176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tutoring)
Number of subjects: 581
Study 10965722 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring with propofol
Number of subjects: 160
Study 10965722 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring with sevoflurane
Number of subjects: 160
Study 10965722 — intervention group
Group type: COMPARATOR
Intervention: BIS monitoring
Number of subjects: 160
Study 10965722 — intervention group
Group type: COMPARATOR
Intervention: No BIS monitoring with propofol
Number of subjects: 160
Study 10965722 — intervention group
Group type: COMPARATOR
Intervention: No BIS monitoring with sevoflurane
Number of subjects: 160
Study 9200248 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate KR
Number of subjects: 60
Study 9200248 — intervention group
Group type: COMPARATOR
Intervention: Delayed KR
Number of subjects: 60
Study 9200248 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate KR + form estimation
Number of subjects: 60
Study 9200248 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed KR + form estimation
Number of subjects: 60
Study 1301847 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi Xue granule (QXG)
Number of subjects: 55
Study 1301847 — intervention group
Group type: COMPARATOR
Intervention: Compound Salvia tablet (CST)
Number of subjects: 55
Study 1301847 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TXB2, 6‐keto‐PGF1 alpha (6 Kp) levels in normal subjects
Number of subjects: 55
Study 1301847 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TXB2, 6‐keto‐PGF1 alpha (6 Kp) levels in AP cases
Number of subjects: 55
Study 3927708 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized edetate sodium plus oral tetracycline twice daily for three months
Number of subjects: 10
Study 3927708 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol plus oral tetracycline for three months
Number of subjects: 10
Study 29721732 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diltiazem 2% ointment
Number of subjects: 60
Study 29721732 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 60
Study 26496621 — intervention group
Group type: EXPERIMENTAL
Intervention: Enclomiphene citrate
Number of subjects: 2
Study 26496621 — intervention group
Group type: COMPARATOR
Intervention: Testosterone gel (AndroGel® 1.62%)
Number of subjects: 2
Study 24429320 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood-burning clay cookstove
Number of subjects: 51
Study 24429320 — intervention group
Group type: COMPARATOR
Intervention: Open fire (control)
Number of subjects: 51
Study 23568851 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of lecithin before surgery
Number of subjects: 60
Study 23568851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 20216353 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief parenting intervention
Number of subjects: 96
Study 20216353 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 18492315 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (Voluven); n = 32
Number of subjects: 65
Study 18492315 — intervention group
Group type: COMPARATOR
Intervention: 3% gelatin (Plasmion); n = 33
Number of subjects: 65
Study 16803913 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine education group
Number of subjects: 25
Study 16803913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (taught oral examination skills)
Number of subjects: 25
Study 16803913 — intervention group
Group type: COMPARATOR
Intervention: E1 (initial oral examination)
Number of subjects: 25
Study 16803913 — intervention group
Group type: COMPARATOR
Intervention: E2 (subsequent oral examination)
Number of subjects: 25
Study 14650580 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamadent toothpaste
Number of subjects: 28
Study 14650580 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 28
Study 10985707 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (isolated hypoperfusion)
Number of subjects: 571
Study 10985707 — intervention group
Group type: COMPARATOR
Intervention: Group D (congestion with hypoperfusion)
Number of subjects: 571
Study 10985707 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C
Number of subjects: 571
Study 10985707 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C and Group D
Number of subjects: 571
Study 9117182 — intervention group
Group type: EXPERIMENTAL
Intervention: In-patient multidisciplinary team care
Number of subjects: 80
Study 9117182 — intervention group
Group type: COMPARATOR
Intervention: Routine out-patient care
Number of subjects: 80
Study 8363078 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine
Number of subjects: 40
Study 3487772 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage electrical stimulation with ramp time of 1.0 sec.
Number of subjects: 31
Study 3487772 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage electrical stimulation with ramp time of 3.5 sec.
Number of subjects: 31
Study 3487772 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage electrical stimulation with ramp time of 5.0 sec.
Number of subjects: 31
Study 3487772 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as no ramp time or different stimulation method).
Number of subjects: 31
Study 29244208 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint gaming on a tablet
Number of subjects: 22
Study 29244208 — intervention group
Group type: COMPARATOR
Intervention: Toy play
Number of subjects: 22
Study 29244208 — intervention group
Group type: COMPARATOR
Intervention: Watching TV
Number of subjects: 22
Study 26807050 — intervention group
Group type: EXPERIMENTAL
Intervention: DynaMed
Number of subjects: 28
Study 26807050 — intervention group
Group type: COMPARATOR
Intervention: AccessMedicine
Number of subjects: 28
Study 24752193 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Illinois change of direction test (MICODT)
Number of subjects: 95
Study 24752193 — intervention group
Group type: COMPARATOR
Intervention: Illinois change of direction speed test (ICODT)
Number of subjects: 95
Study 23688265 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine (DFO) combined with deferiprone (DFP) at 75 mg/kg/day
Number of subjects: 20
Study 23688265 — intervention group
Group type: COMPARATOR
Intervention: Deferoxamine (DFO) monotherapy at 50-60 mg/kg 12-24 hr/day sc or iv 7 times weekly
Number of subjects: 20
Study 21082587 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure Tracks™
Number of subjects: 30
Study 21082587 — intervention group
Group type: COMPARATOR
Intervention: Standard walker
Number of subjects: 30
Study 18853561 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced image contrast in a video-based driving simulator
Number of subjects: 0
Study 15701145 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 0
Study 12714435 — intervention group
Group type: EXPERIMENTAL
Intervention: Seropositivity for P. gingivalis
Number of subjects: 1163
Study 12714435 — intervention group
Group type: EXPERIMENTAL
Intervention: High combined antibody response
Number of subjects: 1163
Study 12714435 — intervention group
Group type: EXPERIMENTAL
Intervention: High combined antibody response (adjusted for age and CHD risk factors)
Number of subjects: 1163
Study 12714435 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined antibody response
Number of subjects: 1163
Study 12714435 — intervention group
Group type: EXPERIMENTAL
Intervention: Edentulousness
Number of subjects: 1163
Study 12410369 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (AP) treatments
Number of subjects: 60
Study 12410369 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (AP) treatments
Number of subjects: 60
Study 10765004 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of octreotide (50 microg every 6 hours) plus intravenous infusion of low-dose insulin (4 units per hour)
Number of subjects: 0
Study 10765004 — intervention group
Group type: COMPARATOR
Intervention: Low-dose insulin alone (4 units per hour)
Number of subjects: 0
Study 7731301 — intervention group
Group type: EXPERIMENTAL
Intervention: xipamide
Number of subjects: 107
Study 7731301 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 107
Study 7731301 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 107
Study 7731301 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 107
Study 1835291 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide aerosol (36 micrograms)
Number of subjects: 21
Study 1835291 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (dose titrated to produce serum levels of 10-20 micrograms/mL)
Number of subjects: 21
Study 7304864 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural opiates
Number of subjects: 75
Study 6737152 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula (PF)
Number of subjects: 0
Study 6737152 — intervention group
Group type: COMPARATOR
Intervention: Pooled pasteurized human milk (HM)
Number of subjects: 0
Study 31957479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy
Number of subjects: 96
Study 31957479 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 96
Study 29265837 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intoxication
Number of subjects: 64
Study 29265837 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 64
Study 27657477 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D/PTH(1-84) ratio
Number of subjects: 1237
Study 24728028 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current therapy (IFC)
Number of subjects: 0
Study 24728028 — intervention group
Group type: COMPARATOR
Intervention: TENS therapy
Number of subjects: 0
Study 24509145 — intervention group
Group type: EXPERIMENTAL
Intervention: Open technique with free eruption (group 1, n=22)
Number of subjects: 43
Study 24509145 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed flap technique (group 2, n=21)
Number of subjects: 43
Study 24509145 — intervention group
Group type: COMPARATOR
Intervention: Quadrant of impacted canines
Number of subjects: 43
Study 20642524 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexiblade
Number of subjects: 32
Study 20642524 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 32
Study 18560462 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL
Number of subjects: 72
Study 18560462 — intervention group
Group type: COMPARATOR
Intervention: Sensar AR40e IOL
Number of subjects: 72
Study 16603634 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 1 mg/kg intravenously at weeks 0 and 4
Number of subjects: 159
Study 16603634 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 2 mg/kg intravenously at weeks 0, 2, 4, and 6
Number of subjects: 159
Study 16603634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 14604452 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 32
Study 14604452 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 32
Study 10891989 — intervention group
Group type: EXPERIMENTAL
Intervention: Rostral medial tegmental lesions
Number of subjects: 6
Study 10891989 — intervention group
Group type: COMPARATOR
Intervention: Pontine base lesions
Number of subjects: 6
Study 10423634 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) 60 microg infused over 2 hours
Number of subjects: 20
Study 10423634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1546144 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 17
Study 1546144 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 200 mg b.i.d.
Number of subjects: 17
Study 1546144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 3896811 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg I.V. followed by oral administration)
Number of subjects: 800
Study 30321746 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Self Reference Training (PSRT)
Number of subjects: 87
Study 30321746 — intervention group
Group type: COMPARATOR
Intervention: Control training (NTC)
Number of subjects: 87
Study 30321746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PSRT and NTC)
Number of subjects: 87
Study 26446117 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 197
Study 26446117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 25458646 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial intervention (TRI)
Number of subjects: 14000
Study 25458646 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin infusion
Number of subjects: 14000
Study 25458646 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral coronary intervention
Number of subjects: 14000
Study 25458646 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin plus glycoprotein IIb/IIIa inhibitors
Number of subjects: 14000
Study 22835702 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic food supplement (containing fructo‐oligosaccharides and probiotic strains)
Number of subjects: 111
Study 22835702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 22835702 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic food supplement
Number of subjects: 111
Study 22835702 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic food supplementation
Number of subjects: 111
Study 21055143 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopetide (2 mg/day i.m. for 75 days)
Number of subjects: 48
Study 21055143 — intervention group
Group type: COMPARATOR
Intervention: Regular therapy
Number of subjects: 48
Study 18948651 — intervention group
Group type: EXPERIMENTAL
Intervention: Shantetra
Number of subjects: 151
Study 18948651 — intervention group
Group type: COMPARATOR
Intervention: Tritanrix HB
Number of subjects: 151
Study 15993253 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI antidepressants (specific SSRIs not detailed)
Number of subjects: 573
Study 15993253 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued SSRI treatment
Number of subjects: 573
Study 15993253 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who switched SSRIs
Number of subjects: 573
Study 15993253 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline patient skepticism about taking an antidepressant
Number of subjects: 573
Study 12669133 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity anticoagulation (target INR = 2)
Number of subjects: 103
Study 12669133 — intervention group
Group type: COMPARATOR
Intervention: Moderate intensity anticoagulation (target INR = 3)
Number of subjects: 103